NUWENuwellis, Inc.

NUWE Stock Price, Valuation & Chart | Nuwellis, Inc.

Compare

$0.740-0.02 (-2.40%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices NUWE intrinsic value NUWE calculated fair value vs price

Overview Financials Dividends Ratios

NUWE Historical price chart

NUWE Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization68.14K

PE Ratio-0.32

EPS-2.28

Trading Volume219.82K

Today's High/Low0.77/0.72

Dividend Yield0.00

52 Week High/Low183.05/0.72

Shares Outstanding92.20K

NUWE Financial Statement

NUWE Analyst ratings

NUWE Analysis & performance metrics

NUWE Company profile

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products…

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console,…

NUWE Management team

Name

Position

John L. ErbCEO

Interim President, Interim Chief Executive Officer & Chairman of the Board

Sandra Eayrs

Chief Human Resources Officer

Neil P. Ayotte Esq.

Senior Vice President, General Counsel, Secretary & Chief Compliance Officer

John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.

Chief Medical Officer & Member of Medical Advisory Board

Robert B. ScottCFO

Chief Financial Officer

Betsy Riemenschneider

Vice President of Sales

Paul Wotta

Corporate Controller

Name

Position

John L. ErbCEO

Interim President, Interim Chief Executive Officer & Chairman of the Board

Sandra Eayrs

Chief Human Resources Officer

Neil P. Ayotte Esq.

Senior Vice President, General Counsel, Secretary & Chief Compliance Officer

John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.

Chief Medical Officer & Member of Medical Advisory Board

Robert B. ScottCFO

Chief Financial Officer

Betsy Riemenschneider

Vice President of Sales

Paul Wotta

Corporate Controller

Management Team

John L. ErbCEO

Interim President, Interim Chief Executive Officer & Chairman of the Board

Sandra Eayrs

Chief Human Resources Officer

Neil P. Ayotte Esq.

Senior Vice President, General Counsel, Secretary & Chief Compliance Officer

John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.

Chief Medical Officer & Member of Medical Advisory Board

Robert B. ScottCFO

Chief Financial Officer

Betsy Riemenschneider

Vice President of Sales

Paul Wotta

Corporate Controller

Management

John L. ErbCEO

Interim President, Interim Chief Executive Officer & Chairman of the Board

Sandra Eayrs

Chief Human Resources Officer

Neil P. Ayotte Esq.

Senior Vice President, General Counsel, Secretary & Chief Compliance Officer

John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.

Chief Medical Officer & Member of Medical Advisory Board

Robert B. ScottCFO

Chief Financial Officer

Betsy Riemenschneider

Vice President of Sales

Paul Wotta

Corporate Controller

Total 7 executives

NUWE Frequently asked questions

What is Nuwellis, Inc. (NUWE) Stock Price?

Current stock price of Nuwellis, Inc. (NUWE) stock is $0.740. The stock price is -2.40% lower in the session. The intraday range can be seen from this page. Volume of Nuwellis, Inc. (NUWE) stock is 219.82K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Nuwellis, Inc. (NUWE) stock price going up or down today?

The stock price of Nuwellis, Inc. (NUWE) can change with earnings, company news, and overall market sentiment. Nuwellis, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Nuwellis, Inc. stock expensive at its current price?

Whether Nuwellis, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NUWE on this page is -0.32. EPS on this page is -2.28. Compare those figures with peers and growth expectations before deciding if the current Nuwellis, Inc. price is justified.

How has the stock price of Nuwellis, Inc. (NUWE) performed historically?

Historical performance for Nuwellis, Inc. (NUWE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NUWE reacted to past earnings and market events.

Should I buy Nuwellis, Inc. (NUWE) stock, at this price?

Buying Nuwellis, Inc. (NUWE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.